Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study

BACKGROUND: The use of dipeptidyl peptidase-4 (DPP-4) inhibitors is increasing among renal transplant patients with diabetes. However, the glucose-lowering efficacies of various DPP-4 inhibitors and their effects on blood cyclosporine levels have not been fully investigated. We compared the glucose-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Jaehyun, Lee, Min Jung, Choe, Eun Yeong, Jung, Chang Hee, Wang, Hye Jin, Kim, Myoung Soo, Kim, Yu Seun, Park, Joong-Yeol, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803553/
https://www.ncbi.nlm.nih.gov/pubmed/26754588
http://dx.doi.org/10.3803/EnM.2016.31.1.161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803553/
https://www.ncbi.nlm.nih.gov/pubmed/26754588
http://dx.doi.org/10.3803/EnM.2016.31.1.161

Ejemplares similares